Safety and efficacy of sofosbuvir and ribavirin for genotype 2 hepatitis C Japanese patients with renal dysfunction
ConclusionsSofosbuvir and ribavirin therapy is highly effective and safe for genotype 2 HCV‐infected Japanese patients. However, attention should be paid to baseline renal function when sofosbuvir‐ and ribavirin‐containing regimens are used for patients with renal dysfunction.
Source: Hepatology Research - Category: Internal Medicine Authors: Takuya Sho, Goki Suda, Atsushi Nagasaka, Yoshiya Yamamoto, Ken Furuya, Kenichi Kumagai, Minoru Uebayashi, Katsumi Terashita, Tomoe Kobayashi, Izumi Tsunematsu, Manabu Onodera, Takashi Meguro, Megumi Kimura, Jun Ito, Machiko Umemura, Takaaki Izumi, Naoki K Tags: Original Article Source Type: research
More News: Chronic Kidney Disease | Clinical Trials | Hepatitis | Hepatitis C | Internal Medicine | Japan Health | Liver | Study | Urology & Nephrology | Virology